LXRX
Lexicon Pharmaceuticals Inc
1.70$
-4.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -240.3% | – | – | – | – | |
| – | -2.6% | -2.0% | -3.5% | -9.4% | -0.8% | +40.8% | +0.0% | -14.2% | -21.9% | -6.8% | +92.7% | – | |
| – | -17.6% | +33.9% | +12.9% | -42.4% | -45.1% | +98.0% | +5.0% | +7.8% | -17.7% | +8.6% | +108.4% | – | |
| – | -154.5% | – | – | +128.0% | +21.4% | -263.5% | – | -227.8% | – | – | – | – | |
| – | -100.0% | – | – | +22.8% | +54.4% | -100.0% | – | – | – | – | – | – | |
| – | – | -312.4% | -88.8% | – | +0.4% | -24.4% | -61.8% | +236.7% | -90.7% | -1,554.7% | +23.4% | – | |
| – | – | -919.9% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -100.0% | – | +66.7% | – | – | |
| – | -99.5% | – | -100.0% | +6,442.9% | -88.6% | +450.0% | +7,767.1% | -100.0% | – | – | -0.6% | – | |
| – | – | +5,387.7% | -182.2% | – | – | -111.7% | – | – | -154.2% | – | -695.3% | – | |
| – | – | – | – | – | – | – | – | -240.3% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.